Filtered By:
Specialty: Cardiovascular & Thoracic Surgery
Procedure: Heart Valve Surgery
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1078 results found since Jan 2013.
Cerebral embolic protection during transcatheter heart interventions
EuroIntervention. 2023 Sep 18;19(7):549-570. doi: 10.4244/EIJ-D-23-00166.ABSTRACTStroke remains a devastating complication of transcatheter aortic valve replacement (TAVR), with the incidence of clinically apparent stroke seemingly fixed at around 3% despite TAVR's significant evolution during the past decade. Embolic showers of debris (calcium, atheroma, valve material, foreign material) are captured in the majority of patients who have TAVR using a filter-based cerebral embolic protection device (CEPD). Additionally, in systematic brain imaging studies, the majority of patients receiving TAVR exhibit new cerebral lesions...
Source: EuroIntervention - September 18, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Victor Alfonso Jimenez Diaz Samir R Kapadia Axel Linke Darren Mylotte Alexandra J Lansky Eberhard Grube Magnus Settergren Rishi Puri Source Type: research
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
EuroIntervention. 2023 Sep 1:EIJ-D-23-00232. doi: 10.4244/EIJ-D-23-00232. Online ahead of print.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-independent, prospe...
Source: EuroIntervention - September 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Moritz Seiffert Reinhard Vonthein Helmut Baumgartner Michael A Borger Yeong-Hoon Choi Volkmar Falk Norbert Frey Andreas Hagendorff Christian Hagl Christian Hamm Inke R K önig Ulf Landmesser Steffen Massberg Hermann Reichenspurner Holger Thiele Raphael Tw Source Type: research
Concomitant tricuspid valve repair for mild-moderate tricuspid regurgitation patients undergoing mitral valve surgery? A meta-analysis and meta-regression
J Cardiovasc Surg (Torino). 2023 Jul 24. doi: 10.23736/S0021-9509.23.12760-1. Online ahead of print.ABSTRACTThe development of tricuspid regurgitation (TR) is a common complication of mitral valve disease. Although severe TR is usually operated on at the same time of mitral valve surgery (MVS), controversies remain regarding whether mild to moderate TR patients should be operated. Concomitant tricuspid valve repair with MVS for mild-moderate TR patients. Electronic databases were searched from inception to November 20, 2022 to include any observational or randomized controlled trials (RCT) that compare concomitant tricuspi...
Source: The Journal of Cardiovascular Surgery - July 24, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Ahmed K Awad Ahmed Sayed Merihan A Elbadawy Adham Ahmed Tom K Ming Wang Haytham Elgharably Source Type: research
Benchmarking Outcomes of Surgical Aortic Valve Replacement in Patients with Bicuspid Aortic Valves
CONCLUSIONS: In this nationally-representative study, 30-day mortality was similar but risk-adjusted 5-year mortality was significantly lower in bicuspid patients undergoing isolated SAVR compared to tricuspid patients, specifically low-risk and normal left ventricular ejection fraction patients. This analyses provides a much-needed 5-year longitudinal national-level benchmark to better inform the discussion of transcatheter vs SAVR in bicuspid patients.PMID:37454786 | DOI:10.1016/j.athoracsur.2023.06.026
Source: The Annals of Thoracic Surgery - July 16, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Sameer A Hirji Zachary Wegermann Sreekanth Vemulapalli Paige Newell Maria Grau-Sepulveda Sean O'Brien Vinod H Thourani Vinay Badhwar Tsuyoshi Kaneko Source Type: research
Transapical Transcatheter Mitral Valve Implantation with the Tendyne Valve: The Swiss Experience
CONCLUSION: Transcatheter mitral valve implantation with Tendyne is feasible to treat polymorbid patients suffering from complex mitral valve disease as well as patients with previous mitral interventions. Perioperative risk was acceptable and procedural success high.PMID:37327913 | DOI:10.1055/s-0043-1769099
Source: The Thoracic and Cardiovascular Surgeon - June 16, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Maria Nucera Jules Miazza Fabien Praz Christoph Kaiser Matthias Siepe David Reineke Oliver Reuthebuch Source Type: research
